Top Analyst Upgrades and Downgrades: BHP Billiton, HP, Kinder Morgan, Marathon Petroleum, Nike, Pfizer, Rite Aid, Tesla and More

Print Email

Stocks were indicated marginally higher on Thursday after the European Central Bank statement remained quite dovish. The major equity indexes all remain just under all-time highs. Even though this bull market may now be well over 8 years old, investors have found different reasons at each selloff to line up and buy stocks aggressively. Those same investors are also searching for new investing ideas and trading ideas.

24/7 Wall St. reviews dozens of analyst research reports each day of the week. Our goal is to find new investing ideas and trading ideas for our readers. Some of these analyst reports cover stocks to buy. Other analyst reports cover stocks to sell or stocks to avoid.

Additional color and commentary has also been added on most of the daily analyst calls. Consensus analyst price target data are from the Thomson Reuters sell-side research service.

These were the top analyst upgrades, downgrades and other research calls from Thursday, July 20, 2017.

BHP Billiton Ltd. (NYSE: BHP) was downgraded to Neutral from Buy at Citigroup, with the firm noting concerns over oil prices. BHP’s ADSs have a 52-week range of $28.02 to $41.79 and has a consensus analyst price target of $36.97.

HP Inc. (NYSE: HPQ) was raised to Outperform from Market Perform and the price target was raised to $22 from $21 at RBC Capital Markets. HP shares closed up 1.7% at $18.70 on Wednesday and were indicated up 1% at $18.90 on Thursday. HP’s 52-week range is $13.55 to $19.58 and its consensus analyst target price is $20.74.

Kinder Morgan, Inc. (NYSE: KMI) was up after telegraphing higher dividends and a $2 billion stock buyback ahead. Jefferies maintained its Hold rating and $20 target. Kinder Morgan has a 52-week range of $18.31 to $23.36 and has a consensus analyst price target of $24.68.

Marathon Petroleum Corp. (NYSE: MPC) was maintained as Buy with a $65 target (versus $54.83 close) at Jefferies, but the firm did remove it from the Franchise Pick list. Marathon Petroleum has a 52-week range of $36.58 to $55.71 and has a consensus analyst price target of $62.94.

Nike, Inc. (NYSE: NKE) was raised to Overweight from Equal Weight at Morgan Stanley. Nike closed up 0.2% at $57.77 on Wednesday and was indicated up 2.3% at $59.09 on Thursday. Nike has a 52-week range of $49.01 to $60.33 and has a consensus analyst price target of $62.11.

Pfizer Inc. (NYSE: PFE) was downgraded to Neutral from Outperform and the price target was cut to $36 from $38 at Credit Suisse. Pfizer closed up 0.78% at $33,62 on Wednesday but was indicated down 0.8% at $33.35 on Thursday. This downgrades said that the firm still sees opportunities for upside over the long-term, but they see more limited drivers of upside over the next 6 months to 12 months. Pfizer has a 52-week range of $29.83 to $37.39 and has a consensus analyst price target of $37.50.

Rite Aid Corporation (NYSE: RAD) was downgraded to Neutral from Buy at Mizuho. Rite Aid closed up 1.9% at $2.63 on Wednesday and was indicated down 0.6% at $2.61 on Thursday, a signal that Rite Aid has already fallen apart so much that this downgrade looks like it is being mostly ignored. Rite Aid has a 52-week range of $2.21 to $8.77 and the consensus analyst target price was $2.88.

Tesla Inc. (NASDAQ: TSLA) was started with a Neutral rating and the price target was assigned as $357 at Citigroup. Despite a Neutral rating, this is still about 10% higher than the $325.26 close from Wednesday. Tesla shares were indicated up 0.5% at $326.99 on Thursday, versus a 52-week range of $178.19 to $386.99 and a consensus analyst target price of $299.35.

You can follow @Jonogg on Twitter if you want the daily analyst calls and other market research calls directly on your feed.

Other analyst calls from this Thursday were seen as follows: